Hypoglycemia possibly caused by CYP2C9-mediated drug interaction in combination with bucolome: a case report

• Päätekijät: Hiroki Tateishi (Tekijä), Daisuke Miyazu (Tekijä), Miho Kurinami (Tekijä), Ichiro Ieiri (Tekijä), Masaaki Hirakawa (Tekijä), Hiroyuki Watanabe (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: BMC, 2021-11-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background Bucolome is a non-steroidal anti-inflammatory drug and uricosuric agent, currently used only in Japan. It is known to induce drug interactions by inhibiting cytochrome P450 (CYP) 2C9. It is often used to enhance the anticoagulant effect of warfarin by utilizing its drug interacti...